Insider Trades of ORBIMED ADVISORS LLC Information

Click on the column header to resort ascending (▲) or descending (▼).

Individual Insider Trades

Company Relation Last Date ▼ Type Tran OwnerType Shares Traded Last Price Shares Held
GLAUKOS CORP Director 06/30/2015 Form 4 Acquisition (Non Open Market) indirect 2,882,064 0 2,854,870
GLAUKOS CORP Director 06/30/2015 Form 4 Disposition (Non Open Market) indirect 11,734 18 2,897,937
RELYPSA INC Beneficial Owner (10%) 05/18/2015 Form 4 Sell indirect 1,457,551 34.13 7,400,000
INTERCEPT PHARMACEUTICALS INC Director 03/26/2015 Form 4 Sell indirect 157,200 281.11 1,120,324
INTERCEPT PHARMACEUTICALS INC Director 03/25/2015 Form 4 Sell indirect 2,800 270.23 1,277,524
INTERCEPT PHARMACEUTICALS INC Director 03/24/2015 Form 4 Sell indirect 45,600 268.13 1,280,324
INTERCEPT PHARMACEUTICALS INC Director 03/23/2015 Form 4 Sell indirect 159,400 270.7 1,325,924
MIRATI THERAPEUTICS, INC. Beneficial Owner (10%) 02/03/2015 Form 4 Buy indirect 100,000 20 1,267,000
RELYPSA INC Beneficial Owner (10%) 09/17/2014 Form 4 Sell indirect 49,000 25.07 8,857,551
RELYPSA INC Beneficial Owner (10%) 09/16/2014 Form 4 Sell indirect 45,000 25.45 8,906,551
INTERCEPT PHARMACEUTICALS INC Director 08/26/2014 Form 4 Sell indirect 61,258 299.13 1,485,324
INTERCEPT PHARMACEUTICALS INC Director 08/25/2014 Form 4 Sell indirect 50,000 294.67 1,546,582
OTONOMY, INC. Beneficial Owner (10%) 08/18/2014 Form 4 Acquisition (Non Open Market) indirect 2,084,523 0 2,084,523
OTONOMY, INC. Beneficial Owner (10%) 08/18/2014 Form 4 Buy indirect 171,875 16 2,256,398
RELYPSA INC Beneficial Owner (10%) 08/15/2014 Form 4 Sell indirect 990,000 26.35 8,951,551
INTERCEPT PHARMACEUTICALS INC Director 08/14/2014 Form 4 Sell indirect 60,000 292.701 1,596,582
LOXO ONCOLOGY, INC. Beneficial Owner (10%) 08/06/2014 Form 4 Acquisition (Non Open Market) indirect 1,900,472 0 1,900,472
LOXO ONCOLOGY, INC. Beneficial Owner (10%) 08/06/2014 Form 4 Buy indirect 275,385 13 2,175,857
ROKA BIOSCIENCE, INC. Beneficial Owner (10%) 07/22/2014 Form 4 Acquisition (Non Open Market) indirect 2,832,364 0 2,810,334
ROKA BIOSCIENCE, INC. Beneficial Owner (10%) 07/22/2014 Form 4 Buy indirect 383,333 12 3,220,429